Showing results (131-140 of 223) with videos related to
Sort By:
Pageof 23
Retrovirology|February 23, 2017
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategiesAntoine Chaillon, Asma Essat, Pierre Frange, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 7, 2023
BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathyJulien Gras, Marie Laure Nere, Marie Noëlle Peraldi, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|October 2, 2019
Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan AfricaAnders Boyd, Menan Gerard Kouamé, Laura Houghtaling, et al.Open Forum Infectious Diseases|July 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero CohortsConstance Delaugerre, Lambert Assoumou, Sarah Maylin, et al.AIDS (London, England)|January 16, 2008
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patientsJean-François Delfraissy, Philippe Flandre, Constance Delaugerre, et al.The Lancet. HIV|December 1, 2019
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trialGuillemette Antoni, Cécile Tremblay, Constance Delaugerre, et al.Journal of Medical Virology|July 20, 2004
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patientsAnne-Geneviève Marcelin, Dissou Affolabi, Claire Lamotte, et al.Journal of Virology|January 10, 2020
A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus InfectionAthena Labeau, Etienne Simon-Loriere, Mohamed-Lamine Hafirassou, et al.AIDS (London, England)|October 6, 2018
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy eraHélène Roul, Murielle Mary-Krause, Jade Ghosn, et al.AIDS (London, England)|December 3, 2019
Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxisJulien Gras, Nadia Mahjoub, Isabelle Charreau, et al.Pageof 23